SRPT logo

Sarepta Therapeutics (SRPT) CAPEX

annual CAPEX:

$146.96M+$59.61M(+68.25%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual capital expenditures is $146.96 million, with the most recent change of +$59.61 million (+68.25%) on December 31, 2024.
  • During the last 3 years, SRPT annual CAPEX has risen by +$106.16 million (+260.20%).
  • SRPT annual CAPEX is now at all-time high.

Performance

SRPT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

quarterly CAPEX:

$45.89M+$7.81M(+20.50%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly capital expenditures is $45.89 million, with the most recent change of +$7.81 million (+20.50%) on March 1, 2025.
  • Over the past year, SRPT quarterly CAPEX has increased by +$3.44 million (+8.12%).
  • SRPT quarterly CAPEX is now at all-time high.

Performance

SRPT quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

TTM CAPEX:

$150.40M+$3.44M(+2.34%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT TTM capital expenditures is $150.40 million, with the most recent change of +$3.44 million (+2.34%) on March 1, 2025.
  • Over the past year, SRPT TTM CAPEX has increased by +$30.19 million (+25.12%).
  • SRPT TTM CAPEX is now at all-time high.

Performance

SRPT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTcash flow metrics

SRPT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+68.3%+8.1%+25.1%
3 y3 years+260.2%+726.7%+496.8%
5 y5 years+146.4%+403.2%+186.5%

SRPT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+355.7%at high+726.7%at high+496.8%
5 y5-yearat high+355.7%at high+916.4%at high+496.8%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

SRPT CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$45.89M(+20.5%)
$150.40M(+2.3%)
Dec 2024
$146.96M(+68.2%)
$38.08M(+2.2%)
$146.96M(+14.9%)
Sep 2024
-
$37.26M(+27.8%)
$127.91M(-2.7%)
Jun 2024
-
$29.17M(-31.3%)
$131.42M(+9.3%)
Mar 2024
-
$42.44M(+122.9%)
$120.21M(+37.6%)
Dec 2023
$87.34M(+170.8%)
$19.04M(-53.3%)
$87.34M(+14.2%)
Sep 2023
-
$40.77M(+127.1%)
$76.47M(+69.4%)
Jun 2023
-
$17.95M(+87.4%)
$45.16M(+24.5%)
Mar 2023
-
$9.58M(+17.3%)
$36.28M(+12.5%)
Dec 2022
$32.25M(-21.0%)
$8.17M(-13.6%)
$32.25M(+12.8%)
Sep 2022
-
$9.46M(+4.2%)
$28.60M(+0.8%)
Jun 2022
-
$9.08M(+63.5%)
$28.39M(+12.6%)
Mar 2022
-
$5.55M(+22.9%)
$25.20M(-38.2%)
Dec 2021
$40.80M(-50.4%)
$4.51M(-51.1%)
$40.80M(-37.1%)
Sep 2021
-
$9.24M(+56.8%)
$64.89M(-19.8%)
Jun 2021
-
$5.89M(-72.1%)
$80.96M(-14.1%)
Mar 2021
-
$21.15M(-26.1%)
$94.23M(+14.6%)
Dec 2020
$82.20M(+37.9%)
$28.61M(+13.1%)
$82.20M(+16.0%)
Sep 2020
-
$25.30M(+32.0%)
$70.85M(+28.9%)
Jun 2020
-
$19.17M(+110.2%)
$54.98M(+4.7%)
Mar 2020
-
$9.12M(-47.2%)
$52.49M(-12.0%)
Dec 2019
$59.63M(-2.5%)
$17.26M(+83.0%)
$59.63M(-0.5%)
Sep 2019
-
$9.43M(-43.5%)
$59.94M(-16.4%)
Jun 2019
-
$16.68M(+2.6%)
$71.68M(+11.0%)
Mar 2019
-
$16.26M(-7.4%)
$64.58M(+5.6%)
Dec 2018
$61.16M(+188.3%)
$17.57M(-17.0%)
$61.16M(+27.1%)
Sep 2018
-
$21.17M(+121.0%)
$48.11M(+38.7%)
Jun 2018
-
$9.58M(-25.4%)
$34.70M(+22.4%)
Mar 2018
-
$12.84M(+183.9%)
$28.34M(+33.6%)
Dec 2017
$21.21M(+209.0%)
$4.52M(-41.7%)
$21.21M(+5.9%)
Sep 2017
-
$7.75M(+140.3%)
$20.04M(+49.0%)
Jun 2017
-
$3.23M(-43.5%)
$13.45M(+22.3%)
Mar 2017
-
$5.71M(+70.7%)
$11.00M(+60.2%)
Dec 2016
$6.87M(+42.1%)
$3.35M(+187.2%)
$6.87M(+35.8%)
Sep 2016
-
$1.17M(+49.9%)
$5.05M(-6.0%)
Jun 2016
-
$777.00K(-50.8%)
$5.38M(-2.0%)
Mar 2016
-
$1.58M(+2.8%)
$5.49M(+13.6%)
Dec 2015
$4.83M(-82.0%)
$1.53M(+3.1%)
$4.83M(-28.5%)
Sep 2015
-
$1.49M(+68.1%)
$6.76M(-62.8%)
Jun 2015
-
$886.00K(-4.0%)
$18.16M(-17.9%)
Mar 2015
-
$923.00K(-73.3%)
$22.13M(-17.5%)
Dec 2014
$26.82M(+610.6%)
$3.46M(-73.2%)
$26.82M(+11.3%)
Sep 2014
-
$12.90M(+166.0%)
$24.10M(+87.1%)
Jun 2014
-
$4.85M(-13.7%)
$12.88M(+44.3%)
Mar 2014
-
$5.62M(+667.8%)
$8.93M(+136.4%)
Dec 2013
$3.77M(+229.7%)
$732.00K(-56.4%)
$3.77M(+8.9%)
Sep 2013
-
$1.68M(+87.2%)
$3.47M(+85.3%)
Jun 2013
-
$896.00K(+90.6%)
$1.87M(+38.2%)
Mar 2013
-
$470.00K(+11.1%)
$1.35M(+18.2%)
Dec 2012
$1.15M(-50.3%)
$423.00K(+422.2%)
$1.15M(-24.0%)
Sep 2012
-
$81.00K(-78.6%)
$1.51M(-13.7%)
Jun 2012
-
$379.00K(+44.7%)
$1.75M(-21.8%)
Mar 2012
-
$262.00K(-66.6%)
$2.23M(-3.2%)
Dec 2011
$2.31M
$784.00K(+145.0%)
$2.31M(+13.8%)
Sep 2011
-
$320.00K(-63.0%)
$2.03M(-7.6%)
Jun 2011
-
$865.00K(+157.4%)
$2.19M(+22.8%)
DateAnnualQuarterlyTTM
Mar 2011
-
$336.00K(-33.5%)
$1.79M(-8.6%)
Dec 2010
$1.95M(-2.0%)
$505.00K(+3.7%)
$1.95M(-19.1%)
Sep 2010
-
$487.00K(+6.3%)
$2.42M(+6.9%)
Jun 2010
-
$458.00K(-9.1%)
$2.26M(+2.6%)
Mar 2010
-
$504.00K(-47.9%)
$2.20M(+10.4%)
Dec 2009
$1.99M(+63.8%)
$967.00K(+193.0%)
$1.99M(+36.4%)
Sep 2009
-
$330.00K(-17.7%)
$1.46M(+11.4%)
Jun 2009
-
$401.00K(+35.5%)
$1.31M(+11.8%)
Mar 2009
-
$296.00K(-31.9%)
$1.17M(-3.5%)
Dec 2008
$1.22M(-42.8%)
$434.40K(+140.5%)
$1.22M(+10.0%)
Sep 2008
-
$180.60K(-31.3%)
$1.11M(-30.1%)
Jun 2008
-
$263.00K(-22.4%)
$1.58M(-14.8%)
Mar 2008
-
$339.00K(+4.8%)
$1.86M(-12.7%)
Dec 2007
$2.13M(+46.3%)
$323.60K(-50.7%)
$2.13M(+6.2%)
Sep 2007
-
$656.50K(+22.3%)
$2.00M(+8.8%)
Jun 2007
-
$537.00K(-12.0%)
$1.84M(+3.8%)
Mar 2007
-
$610.00K(+205.3%)
$1.77M(+22.0%)
Dec 2006
$1.45M(-1.0%)
$199.80K(-59.6%)
$1.45M(-20.5%)
Sep 2006
-
$494.20K(+5.1%)
$1.83M(+10.5%)
Jun 2006
-
$470.30K(+62.5%)
$1.65M(+11.0%)
Mar 2006
-
$289.50K(-49.5%)
$1.49M(+1.5%)
Dec 2005
$1.47M(+37.1%)
$573.60K(+78.7%)
$1.47M(+27.8%)
Sep 2005
-
$321.00K(+4.9%)
$1.15M(-10.3%)
Jun 2005
-
$306.10K(+14.6%)
$1.28M(+7.8%)
Mar 2005
-
$267.20K(+5.2%)
$1.19M(+11.0%)
Dec 2004
$1.07M(-34.7%)
$254.10K(-43.9%)
$1.07M(-5.0%)
Sep 2004
-
$453.00K(+111.8%)
$1.13M(+27.4%)
Jun 2004
-
$213.90K(+43.3%)
$884.40K(-12.6%)
Mar 2004
-
$149.30K(-51.9%)
$1.01M(-38.3%)
Dec 2003
$1.64M(-41.0%)
$310.70K(+47.6%)
$1.64M(-23.9%)
Sep 2003
-
$210.50K(-38.3%)
$2.16M(-17.7%)
Jun 2003
-
$341.10K(-56.1%)
$2.62M(-3.2%)
Mar 2003
-
$777.60K(-6.0%)
$2.71M(-2.6%)
Dec 2002
$2.78M(-33.5%)
$827.00K(+22.9%)
$2.78M(-26.4%)
Sep 2002
-
$672.70K(+56.9%)
$3.77M(-4.0%)
Jun 2002
-
$428.80K(-49.5%)
$3.93M(-1.9%)
Mar 2002
-
$849.10K(-53.4%)
$4.01M(-4.1%)
Dec 2001
$4.18M(+413.7%)
$1.82M(+119.0%)
$4.18M(+58.4%)
Sep 2001
-
$831.40K(+64.5%)
$2.64M(+24.8%)
Jun 2001
-
$505.40K(-50.4%)
$2.11M(+19.0%)
Mar 2001
-
$1.02M(+263.8%)
$1.78M(+118.4%)
Dec 2000
$813.20K(+306.6%)
$280.30K(-9.0%)
$813.10K(+28.5%)
Sep 2000
-
$308.00K(+83.1%)
$632.80K(+94.8%)
Jun 2000
-
$168.20K(+197.2%)
$324.80K(+107.4%)
Mar 2000
-
$56.60K(-43.4%)
$156.60K(-21.7%)
Dec 1999
$200.00K(-91.3%)
$100.00K(>+9900.0%)
$200.00K(0.0%)
Sep 1999
-
$0.00(0.0%)
$200.00K(-91.7%)
Jun 1999
-
$0.00(-100.0%)
$2.40M(0.0%)
Mar 1999
-
$100.00K(0.0%)
$2.40M(+4.3%)
Dec 1998
$2.30M(+666.7%)
$100.00K(-95.5%)
$2.30M(-4.2%)
Sep 1998
-
$2.20M(+1000.0%)
$2.40M(+700.0%)
Dec 1997
$300.00K(+200.0%)
$200.00K(>+9900.0%)
$300.00K(+200.0%)
Sep 1997
-
$0.00(0.0%)
$100.00K(0.0%)
Jun 1997
-
$0.00(-100.0%)
$100.00K(0.0%)
Mar 1997
-
$100.00K
$100.00K
Dec 1996
$100.00K
-
-

FAQ

  • What is Sarepta Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual CAPEX year-on-year change?
  • What is Sarepta Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly CAPEX year-on-year change?
  • What is Sarepta Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Sarepta Therapeutics?
  • What is Sarepta Therapeutics TTM CAPEX year-on-year change?

What is Sarepta Therapeutics annual capital expenditures?

The current annual CAPEX of SRPT is $146.96M

What is the all time high annual CAPEX for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual capital expenditures is $146.96M

What is Sarepta Therapeutics annual CAPEX year-on-year change?

Over the past year, SRPT annual capital expenditures has changed by +$59.61M (+68.25%)

What is Sarepta Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of SRPT is $45.89M

What is the all time high quarterly CAPEX for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly capital expenditures is $45.89M

What is Sarepta Therapeutics quarterly CAPEX year-on-year change?

Over the past year, SRPT quarterly capital expenditures has changed by +$3.44M (+8.12%)

What is Sarepta Therapeutics TTM capital expenditures?

The current TTM CAPEX of SRPT is $150.40M

What is the all time high TTM CAPEX for Sarepta Therapeutics?

Sarepta Therapeutics all-time high TTM capital expenditures is $150.40M

What is Sarepta Therapeutics TTM CAPEX year-on-year change?

Over the past year, SRPT TTM capital expenditures has changed by +$30.19M (+25.12%)
On this page